{"id":"helicobacter-pylori-eradication","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Diarrhea"},{"rate":"5-15","effect":"Nausea"},{"rate":"5-10","effect":"Abdominal discomfort"},{"rate":"5-10","effect":"Taste disturbance"},{"rate":"5-10","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"H. pylori eradication typically employs triple or quadruple therapy combining proton pump inhibitors with antibiotics (such as amoxicillin, clarithromycin, or metronidazole) to suppress gastric acid and kill the bacteria. This approach aims to prevent peptic ulcer disease, gastric cancer, and other H. pylori-associated conditions. The National Cancer Center's marketed regimen represents a standardized eradication protocol.","oneSentence":"Helicobacter pylori eradication involves the use of antibiotic-based combination therapy to eliminate the bacterium from the gastric mucosa.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:31:57.658Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Helicobacter pylori infection eradication"},{"name":"Prevention of gastric cancer"},{"name":"Prevention of peptic ulcer disease"}]},"trialDetails":[{"nctId":"NCT06561711","phase":"PHASE4","title":"Optimization of Minocycline for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":480},{"nctId":"NCT06977841","phase":"NA","title":"Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2025-06-10","conditions":"Helicobacter Pylori Eradication, Adverse Reaction","enrollment":640},{"nctId":"NCT07487142","phase":"PHASE3","title":"Prevalence of Asymptomatic H Pylori Infection Among Patients Undergoing PCI and Impact of Its Eradication on Occurrence of GIT Symptoms and Bleeding\"","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2024-06-10","conditions":"H Pylori Infection","enrollment":121},{"nctId":"NCT00713947","phase":"PHASE4","title":"Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus Control","status":"WITHDRAWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2008-04","conditions":"Positive Helicobacter Pylori Serology, Coronary Thrombosis, Supra-aortic Artery Thrombosis","enrollment":""},{"nctId":"NCT07179159","phase":"NA","title":"Efficacy and Safety of 14-Day Vonoprazan-Based Dual Therapy Versus Quadruple Therapy for Helicobacter Pylori Eradication: A Multicentre, Non-Inferiority Randomized Controlled Trial","status":"RECRUITING","sponsor":"Yanqing Li","startDate":"2025-09-09","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":372},{"nctId":"NCT06340334","phase":"NA","title":"Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-03-31","conditions":"Helicobacter Pylori Infection, Tegoprazan, Furazolidone","enrollment":400},{"nctId":"NCT06412588","phase":"NA","title":"Dual Therapy With Vonoprazan Plus Amoxicillin or Doxycycline Versus Bismuth Quadruple Therapy for Helicobacter Pylori Eradication.","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-06-15","conditions":"Helicobacter Pylori Infection","enrollment":579},{"nctId":"NCT06529159","phase":"NA","title":"H. Pylori Eradication With Argon Plasma During Endoscopy","status":"RECRUITING","sponsor":"Christopher C. Thompson, MD, MSc","startDate":"2025-07-08","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":20},{"nctId":"NCT07439445","phase":"NA","title":"Simplified Dual Regimen Guided by Fecal Clarithromycin Resistance Gene Detection for First-line H. Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2026-02-24","conditions":"Helicobacter Pylori Infection","enrollment":70},{"nctId":"NCT06943794","phase":"NA","title":"Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-03-30","conditions":"Gastric (Stomach) Cancer","enrollment":4824},{"nctId":"NCT06340724","phase":"PHASE3","title":"Banxiaxiexin Decoction Combined With Vonoprazan-Amoxicillin Dual Therapy in H. Pylori Eradication","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-02-15","conditions":"Helicobacter Pylori Infection","enrollment":104},{"nctId":"NCT07408271","phase":"","title":"The Impact of Helicobacter Pylori Eradication on the Vaginal Microecology Change","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2023-03-24","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Eradication Antibiotic","enrollment":83},{"nctId":"NCT07293910","phase":"PHASE2","title":"Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Tanta University","startDate":"2026-02-15","conditions":"HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, Helicobacter Pylori Gastrointestinal Tract Infection","enrollment":66},{"nctId":"NCT07374822","phase":"","title":"Real-World Study of Helicobacter Pylori Eradication Success and Its Determinants","status":"COMPLETED","sponsor":"Run-hua Li","startDate":"2024-05-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":3000},{"nctId":"NCT06510010","phase":"PHASE2","title":"Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer","status":"RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2024-12-31","conditions":"Chemotherapy Effect","enrollment":198},{"nctId":"NCT07358130","phase":"NA","title":"Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy and Bismuth Quadruple Therapy","status":"RECRUITING","sponsor":"Kaohsiung Medical University","startDate":"2025-10-21","conditions":"Helicobacter Pylori Infection","enrollment":552},{"nctId":"NCT03900910","phase":"NA","title":"Gastric Cancer Prevention for Indigenous Peoples","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2018-01-01","conditions":"Gastric Cancer","enrollment":50000},{"nctId":"NCT07352098","phase":"NA","title":"7-day High-Dose Vonoprazan-amoxicillin Dual Therapy Versus 14-day Vonoprazan-amoxicillin Dual Therapy for H. Pylori","status":"NOT_YET_RECRUITING","sponsor":"Yueyue Li","startDate":"2026-02-01","conditions":"Helicobacter","enrollment":290},{"nctId":"NCT05647278","phase":"PHASE4","title":"Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1)","status":"COMPLETED","sponsor":"Zhang Xiaofeng,MD","startDate":"2023-11-01","conditions":"Helicobacter Pylori Infection","enrollment":370},{"nctId":"NCT06349486","phase":"NA","title":"Efficacies of Bismuth-amoxicillin-vonoprazan Triple Therapy, Vonoprazan-amoxicillin Dual Therapy and Proton Pump Inhibitor-based Standard Triple Therapy for Hp Eradication","status":"RECRUITING","sponsor":"Kaohsiung Medical University","startDate":"2023-11-28","conditions":"Helicobacter Pylori Eradication","enrollment":390},{"nctId":"NCT07344506","phase":"PHASE4","title":"CURE-H. Pylori: A Trial on the Combination of Anti-Ulcerants and Levofloxacin-Based Therapy for Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Dow University of Health Sciences","startDate":"2025-05-01","conditions":"H. Pylori Gastrointestinal Disease, H.Pylori Infection, H.Pylori Eradication Rate","enrollment":942},{"nctId":"NCT07340593","phase":"","title":"Helicobacter Pylori Infection and Gastric Diseases in Lao PDR: First Community-Wide Population-Based Study","status":"COMPLETED","sponsor":"Zero Helicobacter IGAN Network","startDate":"2023-12-18","conditions":"Gastric Cancer Screening, Prevention and Control, Helicobacter Eradication","enrollment":1251},{"nctId":"NCT07333001","phase":"","title":"Efficacy and Safety of 7-day Triple Therapy Containing Amoxicillin and Tetracycline Versus 14-day Dual Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Yueyue Li","startDate":"2025-11-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":508},{"nctId":"NCT07294846","phase":"PHASE1","title":"Drug Interaction Study on Linaprazan Glurate Capsules","status":"COMPLETED","sponsor":"Jiangsu Sinorda Biomedicine Co., Ltd","startDate":"2025-09-08","conditions":"Healthy Volunteers, Patients","enrollment":56},{"nctId":"NCT07306988","phase":"PHASE4","title":"Eradication of Helicobacter Pylori Improves Metabolic Syndrome Through Modulation of Gut Microbiota.","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-04-17","conditions":"HELICOBACTER PYLORI INFECTIONS, Metabolic Syndrome","enrollment":120},{"nctId":"NCT07285096","phase":"","title":"P-CABs-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Yueyue Li","startDate":"2025-12-16","conditions":"Helicobacter Pylori Infection","enrollment":1730},{"nctId":"NCT07293169","phase":"","title":"Helicobacter Pylori Infection Among Women With Recurrent Abortion of Unknown Cause","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-12","conditions":"Helicobacter Pylori Infection, Susceptibility to","enrollment":100},{"nctId":"NCT07104318","phase":"PHASE3","title":"Personalized vs Standard of Care Treatment for Helicobacter Pylori Eradication Among Veterans","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-04-01","conditions":"Helicobacter Pylori","enrollment":360},{"nctId":"NCT05926804","phase":"NA","title":"A \"Screen and Treat\" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of Chile","status":"RECRUITING","sponsor":"Miguel O'Ryan Gallardo","startDate":"2022-08-02","conditions":"Helicobacter Pylori Infection","enrollment":500},{"nctId":"NCT07272681","phase":"","title":"Effect of H. Pylori Eradication on The Improvement of Gastrointestinal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Amany Usama Ahmed Arafa","startDate":"2025-12-20","conditions":"Helicobacter Pylori Infection, Dyspepsia, Gastrointestinal Symptoms","enrollment":100},{"nctId":"NCT06751121","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2024-02-06","conditions":"Helicobacter Pylori Infection, Helicobacter Pylori Infected Patients, Helicobacter Pylori Infected Subjects","enrollment":461},{"nctId":"NCT07246681","phase":"PHASE3","title":"Lignin in Treatment of Helicobacter Pylori Infection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Zagazig University","startDate":"2025-10-31","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":70},{"nctId":"NCT07242456","phase":"PHASE2, PHASE3","title":"Head-to-head Study of Tegoprazan 50 mg BID Plus Amoxicillin 1 g TID vs. Vonoprazan 20 mg BID Plus Amoxicillin 1 g TID for H. Pylori Eradication","status":"RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2025-02-17","conditions":"Helicobacter Pylori Infection","enrollment":240},{"nctId":"NCT07242443","phase":"PHASE4","title":"Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori）","status":"NOT_YET_RECRUITING","sponsor":"First People's Hospital of Hangzhou","startDate":"2025-11-20","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":240},{"nctId":"NCT07232095","phase":"PHASE4","title":"7-Day Vonoprazan, High-Dose Amoxicillin, and Bismuth Therapy","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-11-30","conditions":"Helicobacter Pylori","enrollment":316},{"nctId":"NCT07211880","phase":"NA","title":"Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study","status":"COMPLETED","sponsor":"Zero Helicobacter IGAN Network","startDate":"2019-12-05","conditions":"H.Pylori, Gastric Cancer, H Pylori Eradication","enrollment":1043},{"nctId":"NCT07179237","phase":"PHASE2","title":"Efficacy of Carminal in Helicobacter Pylori Gastritis","status":"RECRUITING","sponsor":"Catalysis SL","startDate":"2025-08-04","conditions":"H Pylori Gastritis, H Pylori Infection, H Pylori Eradication","enrollment":80},{"nctId":"NCT04728516","phase":"PHASE4","title":"The Effect of Dual Eradication Therapy vs PPI on Gastrointestinal Bleeding in ACS Patients","status":"RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-04-12","conditions":"Acute Coronary Syndrome, Helicobacter Pylori Infection","enrollment":2600},{"nctId":"NCT05874544","phase":"PHASE4","title":"Rescue Therapy for Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2023-05-16","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT07167511","phase":"","title":"Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Yueyue Li","startDate":"2022-01-01","conditions":"Helicobacter Pylori Infection","enrollment":1730},{"nctId":"NCT07150286","phase":"NA","title":"Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq","status":"COMPLETED","sponsor":"Al-Mustansiriyah University","startDate":"2024-09-01","conditions":"Immune Thrombocytopenic Purpura, HELICOBACTER PYLORI INFECTIONS","enrollment":100},{"nctId":"NCT04332848","phase":"PHASE4","title":"Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2020-07-28","conditions":"Helicobacter Pylori Infection","enrollment":360},{"nctId":"NCT07146594","phase":"PHASE4","title":"Clinical Evaluation of a 14day Modified Bismuth Quadruple Therapy for the Eradication of Helicobacter Pylori in a High Clarithromycin and Metronidazole Resistance Area Regarding Patients With Peptic Ulcer and Non Ulcer Dyspepsia","status":"NOT_YET_RECRUITING","sponsor":"Athens Medical Center","startDate":"2025-08-20","conditions":"Helicobacter Pylori Gastritis, Helicobacter Eradication","enrollment":150},{"nctId":"NCT07142798","phase":"NA","title":"to Assess the Eradication Rate of 14-day Bismuth/Amoxicillin/PCAB Triple Therapy for the Treatment of Helicobacter Pylori Infection","status":"ENROLLING_BY_INVITATION","sponsor":"Kaohsiung Medical University","startDate":"2024-09-26","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":200},{"nctId":"NCT07130253","phase":"NA","title":"Efficacy of Vonoprazan-based Rescue Therapy for H. Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2025-08-18","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":220},{"nctId":"NCT07068607","phase":"PHASE4","title":"Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2025-04-01","conditions":"Gastritis, Indigestion, Helicobacter Pylori Infection, Gastric Cancer, Peptic Ulcer","enrollment":400},{"nctId":"NCT07115173","phase":"PHASE4","title":"Clinical Trial to Evaluate the Efficacy of Probit-Based Triple Therapy for Helicobacter Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Samsung Medical Center","startDate":"2025-12-01","conditions":"Helicobacter Infection","enrollment":103},{"nctId":"NCT07121205","phase":"","title":"High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)","status":"COMPLETED","sponsor":"Liyueyue","startDate":"2025-06-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":1600},{"nctId":"NCT07086937","phase":"NA","title":"Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children","status":"COMPLETED","sponsor":"Muhammad Aamir Latif","startDate":"2025-01-01","conditions":"Helicobacter Pylori Infection","enrollment":66},{"nctId":"NCT06499649","phase":"NA","title":"Assessment of the Adjuvant Role of Dietary Supplementation of Antibiotic-tolerant Probiotics in Standard Therapy for the Eradication of Helicobacter Pylori Infection.","status":"COMPLETED","sponsor":"IBSA Farmaceutici Italia Srl","startDate":"2024-07-03","conditions":"Helicobacter Pylori Infection","enrollment":270},{"nctId":"NCT05790525","phase":"PHASE4","title":"Effect of Oral Helicobacter Pylori Infection on the Efficacy of Gastroluminal Helicobacter Pylori Eradication Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-11-22","conditions":"Helicobacter Pylori","enrollment":200},{"nctId":"NCT06514274","phase":"PHASE4","title":"Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2024-09-20","conditions":"Helicobacter Pylori Infection, Chronic Gastritis","enrollment":558},{"nctId":"NCT06168084","phase":"PHASE4","title":"Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Yongquan Shi","startDate":"2023-06-06","conditions":"Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer","enrollment":688},{"nctId":"NCT05742568","phase":"PHASE4","title":"Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2022-12-01","conditions":"Gastritis, Dyspepsia, Helicobacter Pylori Infection","enrollment":124},{"nctId":"NCT07045688","phase":"NA","title":"Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Sohag University","startDate":"2025-05-13","conditions":"H. Pylori Infection","enrollment":150},{"nctId":"NCT05024864","phase":"NA","title":"HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Karolinska Institutet","startDate":"2021-11-17","conditions":"Myocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding","enrollment":20000},{"nctId":"NCT07021729","phase":"PHASE4","title":"Comparison of Two Treatment Regimens of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Rehman Medical Institute - RMI","startDate":"2025-12","conditions":"Helicobacter Pylori Infection","enrollment":156},{"nctId":"NCT06959368","phase":"PHASE4","title":"Vonoprazan Evaluation Compared to Standard Triple Therapy in Helicobacter Pylori eRadication","status":"RECRUITING","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2025-03-25","conditions":"Helicobacter Pylori Infection","enrollment":484},{"nctId":"NCT06929962","phase":"PHASE4","title":"VA Dual Sequential Therapy","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-04-24","conditions":"Helicobacter Pylori Infection","enrollment":600},{"nctId":"NCT06973889","phase":"PHASE2","title":"Evaluation of IgY Antibody Efficacy in Egg Yolk Against Helicobacter Pylori in Bacterial Elimination and Clinical Symptoms Improvement of Gastrointestinal Patients","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","startDate":"2023-12-04","conditions":"HELICOBACTER PYLORI INFECTIONS, Gastrointestinal Disease","enrollment":60},{"nctId":"NCT06292546","phase":"NA","title":"The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment","status":"COMPLETED","sponsor":"Zhongshan Hospital (Xiamen), Fudan University","startDate":"2024-01-31","conditions":"Gut Microbiota, Metabolic Disturbance, Helicobacter Pylori Eradication","enrollment":72},{"nctId":"NCT06964334","phase":"PHASE3","title":"The Effect of Vitamin D Supplement as Adjuvant Therapy in Eradication of Helicobacter Pylori Infection","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2025-06-01","conditions":"Helicobacter Pylori Infection","enrollment":70},{"nctId":"NCT02047994","phase":"PHASE4","title":"Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality","status":"RECRUITING","sponsor":"International Agency for Research on Cancer","startDate":"2013-03","conditions":"Helicobacter Pylori Infections, Atrophic Gastritis, Gastric Cancer","enrollment":30000},{"nctId":"NCT03130452","phase":"PHASE4","title":"Helicobacter Pylori Eradication Study","status":"COMPLETED","sponsor":"Inje University","startDate":"2016-12-17","conditions":"Helicobacter Pylori Infection","enrollment":423},{"nctId":"NCT06431737","phase":"","title":"Comparison of Twice- and Four-times-daily Amoxicillin Administration in 2-week Tegoprazan-based H. Pylori Eradication","status":"COMPLETED","sponsor":"Soonchunhyang University Hospital","startDate":"2024-04-01","conditions":"H.Pylori Infection","enrollment":100},{"nctId":"NCT06682533","phase":"","title":"Tegoprazan- Versus PPI-based H. Pylori Eradication","status":"RECRUITING","sponsor":"Soonchunhyang University Hospital","startDate":"2024-12-01","conditions":"H.Pylori Infection","enrollment":200},{"nctId":"NCT03897244","phase":"PHASE4","title":"Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2019-05-30","conditions":"Helicobacter Pylori Infection","enrollment":603},{"nctId":"NCT06901375","phase":"EARLY_PHASE1","title":"Zuojin Wan Combined with Vonoprazan-Amoxicillin Dual Therapy in H.Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-05","conditions":"Helicobacter Pylori Infection","enrollment":136},{"nctId":"NCT05065138","phase":"NA","title":"Comparison of Helicobacter Pylori Eradication Effect Before and After Training of Gastroenterologists","status":"COMPLETED","sponsor":"Shandong University","startDate":"2022-03-01","conditions":"Helicobacter Pylori Infection","enrollment":1025},{"nctId":"NCT06811207","phase":"PHASE3","title":"Comparison of the Efficacies of Two Novel Dose Dual Therapies in the First-line Helicobacter Pylori Eradication","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2025-02-01","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":300},{"nctId":"NCT06823791","phase":"PHASE1, PHASE2","title":"Furazolidone Quadruple Regimen Eradicate H. Pylori Infection","status":"COMPLETED","sponsor":"Liaocheng People's Hospital","startDate":"2022-08-01","conditions":"Helicobacter Pylori Infection, Eradication","enrollment":493},{"nctId":"NCT06818591","phase":"","title":"Preventive Effect of H.Pylori Eradication on Osteoporosis","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2003-05","conditions":"HELICOBACTER PYLORI INFECTIONS, Osteoporosis","enrollment":846},{"nctId":"NCT06576882","phase":"PHASE3","title":"7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-06-30","conditions":"Helicobacter Pylori Infection, Gastritis, Vonoprazan","enrollment":326},{"nctId":"NCT06777732","phase":"EARLY_PHASE1","title":"The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-03","conditions":"Helicobacter Pylori Infection","enrollment":672},{"nctId":"NCT06760065","phase":"PHASE3","title":"Comparison of Keverprazan Hydrochloride-Amoxicillin Dual Therapy and Susceptibility-Guided Quadruple Therapy for Helicobacter Pylori Rescue Treatment","status":"NOT_YET_RECRUITING","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","startDate":"2025-01-15","conditions":"Helicobacter Pylori Infection Helicobacter Pylori Eradication Patient Education","enrollment":316},{"nctId":"NCT05874570","phase":"PHASE4","title":"Doxycycline for Helicobacter Pylori Rescue Treatment","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2023-06-20","conditions":"Helicobacter Pylori Infection","enrollment":368},{"nctId":"NCT06422052","phase":"","title":"Epidemiological Investigation of Helicobacter Pylori-infected Patients and the Effect of Eradication Treatment on Dyspepsia Symptoms","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-03-11","conditions":"Helicobacter Pylori Infection, Dyspepsia","enrollment":2242},{"nctId":"NCT05901051","phase":"PHASE4","title":"High-dose Dual Therapy with Different Administration Frequencies","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2021-03-30","conditions":"Helicobacter Pylori Infection","enrollment":327},{"nctId":"NCT06561698","phase":"PHASE4","title":"High-dose Dual Therapy and Minocycline-cotaining Quadruple Therapy for Helicobacter Pylori Infection","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2024-08-21","conditions":"Helicobacter Pylori Infection","enrollment":200},{"nctId":"NCT04531059","phase":"PHASE4","title":"Rescue Therapy for Helicobacter Pylori Eradication Treatment","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2020-10-15","conditions":"Helicobacter Pylori Infection","enrollment":368},{"nctId":"NCT02112214","phase":"PHASE3","title":"Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Center, Korea","startDate":"2014-06","conditions":"Gastric Cancer, Helicobacter Pylori Infection","enrollment":5224},{"nctId":"NCT06200779","phase":"PHASE4","title":"Tailored Vs. Empirical Helicobacter Pylori Infection Treatment","status":"NOT_YET_RECRUITING","sponsor":"Manuel Coelho da Rocha","startDate":"2025-09","conditions":"Helicobacter Pylori Infection","enrollment":160},{"nctId":"NCT06723197","phase":"PHASE4","title":"Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Shandong University","startDate":"2024-12-10","conditions":"HELICOBACTER PYLORI INFECTIONS","enrollment":330},{"nctId":"NCT06299605","phase":"NA","title":"Triple Versus Quadruple Therapy for the Eradication of Helicobacter Pylori","status":"ENROLLING_BY_INVITATION","sponsor":"Shandong University","startDate":"2024-11-27","conditions":"Helicobacter Pylori Infection","enrollment":375},{"nctId":"NCT03978481","phase":"","title":"Effect of Helicobacter Pylori Eradication After Subtotal Gastrectomy on Survival Rate of Gastric Cancer Patients: Retrospective Study","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","startDate":"2019-01-30","conditions":"Gastric Cancer","enrollment":3700},{"nctId":"NCT05649540","phase":"PHASE4","title":"Optimization of Vonoprazan-based Dual Therapy for Helicobacter Pylori","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-01-20","conditions":"Helicobacter Pylori Infection","enrollment":900},{"nctId":"NCT02387203","phase":"PHASE2","title":"Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mercy Medical Center","startDate":"2015-01","conditions":"Pseudomyxoma Peritonei, Appendiceal Neoplasms","enrollment":80},{"nctId":"NCT06687473","phase":"PHASE4","title":"Susceptibility-guided Bismuth Quadruple Therapy for Multiple-resistant Helicobacter Pylori Strains","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-01-01","conditions":"Helicobacter Pylori, Drug Resistance, Multiple, Virulence Factor","enrollment":13},{"nctId":"NCT06687499","phase":"PHASE4","title":"14-day Susceptibility-guided Bismuth Quadruple Therapy for Multiple Drug Resistant H. Pylori Infection","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2022-08-22","conditions":"Helicobacter Pylori, Drug Resistance, Multiple","enrollment":46},{"nctId":"NCT05475431","phase":"","title":"Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity","status":"COMPLETED","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Comorbidities and Coexisting Conditions, Real-world Outcome","enrollment":1053},{"nctId":"NCT06509139","phase":"PHASE4","title":"Optimal Duration of Bismuth Quadruple Therapy for Helicobacter Pylori Eradication in Females As Compared with Males","status":"ENROLLING_BY_INVITATION","sponsor":"National Cheng-Kung University Hospital","startDate":"2024-07-09","conditions":"Helicobacter Pylori Infection, Sex, Bismuth Quadruple Therapy","enrollment":661},{"nctId":"NCT06162949","phase":"PHASE3","title":"Vonoprazan for Helicobacter Pylori Eradication in Adolescents","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2024-01-01","conditions":"Treatment Effectiveness","enrollment":242},{"nctId":"NCT05649709","phase":"PHASE4","title":"Helicobacter Pylori and Vonoprazan Dual Therapy","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2023-02-13","conditions":"Helicobacter Pylori","enrollment":504},{"nctId":"NCT06168214","phase":"PHASE4","title":"Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication","status":"RECRUITING","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2023-09-04","conditions":"the Eradication Rates of Helicobacter Pylori","enrollment":1404},{"nctId":"NCT06396780","phase":"","title":"Treatment Adherence And Influencing Factors in Children With Helicobacter Pylori Infection During Eradication Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wei XIA, PhD","startDate":"2024-03-30","conditions":"Helicobacter Pylori Infection, Children, Only","enrollment":233},{"nctId":"NCT04527055","phase":"PHASE4","title":"The Efficacy of 10-day and 14-day Bismuth-based Quadruple Therapy in First-line H. Pylori Eradication","status":"ENROLLING_BY_INVITATION","sponsor":"National Cheng-Kung University Hospital","startDate":"2020-05-06","conditions":"Helicobacter Pylori Infection, Dysbiosis, Probiotics","enrollment":312},{"nctId":"NCT05749081","phase":"PHASE4","title":"Helicobacter Pylori and Lacidophilin Tablets in Combination With Vonorazan Dual Therapy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The First Affiliated Hospital of Nanchang University","startDate":"2023-05-13","conditions":"Helicobacter Pylori Infection","enrollment":324},{"nctId":"NCT06457334","phase":"","title":"Effect of Helicobacter Pylori Eradication on Gastroesophageal RefIux Disease (GERD)","status":"RECRUITING","sponsor":"Assiut University","startDate":"2024-01-01","conditions":"GERD","enrollment":100},{"nctId":"NCT05469685","phase":"PHASE4","title":"Efficacy and Safety of Dual Therapy for Helicobacter Pylori Eradication","status":"COMPLETED","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-08-01","conditions":"Helicobacter Pylori Infection","enrollment":914},{"nctId":"NCT06250634","phase":"NA","title":"Esomeprazole/Vonoprazan Combined With High-dose Amoxicillin Dual Therapy for Primary Eradication of Helicobacter Pylori Infection","status":"COMPLETED","sponsor":"The Third Xiangya Hospital of Central South University","startDate":"2024-02-10","conditions":"Helicobacter Pylori Infection","enrollment":806}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE PRERENAL FAILURE"},{"count":1,"reaction":"CHEST DISCOMFORT"},{"count":1,"reaction":"CONVULSION"},{"count":1,"reaction":"DIARRHOEA"},{"count":1,"reaction":"DYSPNOEA"},{"count":1,"reaction":"HYPOMAGNESAEMIA"},{"count":1,"reaction":"LETHARGY"},{"count":1,"reaction":"PALPITATIONS"},{"count":1,"reaction":"RHABDOMYOLYSIS"},{"count":1,"reaction":"VOMITING"}],"_approvalHistory":[],"publicationCount":3956,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Chemoprevention"],"phase":"marketed","status":"active","brandName":"Helicobacter pylori eradication","genericName":"Helicobacter pylori eradication","companyName":"National Cancer Center, Korea","companyId":"national-cancer-center-korea","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Helicobacter pylori eradication involves the use of antibiotic-based combination therapy to eliminate the bacterium from the gastric mucosa. Used for Helicobacter pylori infection eradication, Prevention of gastric cancer, Prevention of peptic ulcer disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}